Showing results (51-60 of 195) with videos related to
Sort By:
Pageof 20
Leukemia|March 23, 1999
Decreased sensitivity of drug-resistant cells towards T cell cytotoxicityC F Classen, S Fulda, C Friesen, et al.Cancer Research|October 10, 1998
Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cellsS Fulda, S A Susin, G Kroemer, et al.Blood|November 8, 2001
Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapyK Stahnke, S Fulda, C Friesen, et al.Cancer Research|June 24, 2000
Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosisC Beltinger, S Fulda, T Kammertoens, et al.Cell Death and Differentiation|July 1, 1996
Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCRI Herr, L Balemans, T Böhler, et al.The EMBO Journal|October 8, 1997
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosisI Herr, D Wilhelm, T Böhler, et al.Cancer Research|September 1, 1997
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cellsS Fulda, H Sieverts, C Friesen, et al.International Journal of Cancer|July 29, 1997
Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokinesJ Fellenberg, H Mau, C Scheuerpflug, et al.Leukemia|June 18, 2004
Betulinic acid-induced apoptosis in leukemia cellsH Ehrhardt, S Fulda, M Führer, et al.Bone Marrow Transplantation|October 2, 2003
Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMTC F Classen, K-M Debatin, W Friedrich, et al.Pageof 20